NSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,106.50
- Market cap
- ₹61,056 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 28.3×Sector 48.7×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Legal & Regulatory
Alkem Laboratories has initiated a forensic audit by Grant Thornton Bharat LLP following alleged misappropriation of funds by a former employee.
Alkem Laboratories Other Announcement
Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Alkem Laboratories Management Change
Alkem Laboratories appointed Laxmikant Tiwari and Nilesh Vartak as Senior Management Personnel effective 12 October 2026. The appointments strengthen pharmaceutical operations and supply chain leadership.
Alkem Laboratories Management Change
Alkem Laboratories CFO Nitin Agrawal resigned effective 30 September 2026 for new opportunities. He was also a Key Managerial Personnel of the company.
Alkem Laboratories Debt & Borrowing: ₹593.5 Cr
Alkem Laboratories issued a Corporate Guarantee of Euro 54.45 Million to HSBC UK Bank for a Euro 49.5 Million term loan taken by its subsidiary, Occlutech Holding.
- Value
- ₹593.5 Cr
Alkem Laboratories Product Launch
Alkem launches NeuCeno (cenobamate), an anti-seizure medication for partial-onset seizures in adults, for the first time in India. The once-daily drug is available in six tablet strengths.
Other business update announcements
All →Durlax Top Surface Business Update
Durlax Top Surface disclosed a CPWD certificate confirming its Luxor products performed satisfactorily at kitchen platforms and vanity counters at the PM's Principal Secretary bungalow. The filing carries no monetary amount or contract award.
Libas Consumer Products Business Update
Libas announced a 25% discount voucher for all registered shareholders, valid November 2026 to October 2027. Shareholders claim it via email with demat details.
GAIL (India) Business Update
GAIL revises Durgapur-Haldia and Dhamra-Haldia pipeline completion to March 2027 due to unavailability of hindrance-free fronts. No additional investment is required for either section.
Kirloskar Industries Business Update
Kirloskar Industries forwarded Q1 FY27 unaudited results of subsidiary KFIL to exchanges. The filing discloses revenue, profit, and key financial ratios for the September quarter.
OneSource Specialty Pharma Business Update
OneSource received a USFDA EIR with VAI classification for its Bengaluru SPD facility. This marks completion of the June 2026 inspection with no monetary penalty.
GP Eco Solutions India Business Update
GP Eco Solutions shared a factory showcase video of subsidiary Invergy India's first-phase manufacturing facility. The video highlights production capabilities, infrastructure, and product portfolio.